LYMPHOKINES ON METASTATIC MALIGNANT MELANOMA

淋巴因子对转移性恶性黑色素瘤的作用

• 批准号: 6246793
• 负责人: Fred T Valentine
• 金额: $ 2.39万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-02-12 至 1997-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6246793
• 关键词: Mycobacterium tuberculosis; bacterial antigens; clinical research; clinical trials; human subject; human therapy evaluation; immunological substance; lymphocyte; lymphokines; melanoma; metastasis; neoplasm /cancer immunotherapy; neoplasm /cancer remission /regression; tissue /cell culture

A mixture of soluble lymphokines, prepared by culturing the patients' lymphocytes in vitro with tuberculin PPD, is injected into cutaneous metastatic lesions of malignant melanoma in order to induce regression of metastatic lesions and conceivable regression of metastatic lesions that have not been injected. Laboratory will be utilized for recombinant DNA techniques.

一种可溶性淋巴因子的混合物，通过培养患者的 淋巴细胞体外与结核菌素PPD，注射到皮肤 恶性黑色素瘤的转移性病变，以诱导 转移性病变和转移性病变的可能消退， 没有被注射。实验室将用于重组DNA 技术.